IFP Advisors’s Cidara Therapeutics CDTX Stock Holding History

IFP Advisors’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-49	Closed	-$10.8K	–	5042
2025 Q4	$10.8K	Buy	+49	New	+$7.92K	﹤0.01%	3026
2019 Q1	$1K	Hold	10	–	–	﹤0.01%	2183
2018 Q4	$0	Hold	10	–	–	﹤0.01%	3555
2018 Q3	$1K	Hold	10	–	–	﹤0.01%	3656
2018 Q2	$1K	Buy	+10	New	+$944	﹤0.01%	3699
2016 Q2	–	Sell	-10	Closed	-$1K	–	3858
2016 Q1	$1K	Buy	+10	New	+$2.31K	﹤0.01%	2180

IFP Advisors's CDTX Position: Q1 2026 in Review

IFP Advisors sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 49 shares — an estimated $10.8K sold.

IFP Advisors first reported a position in CDTX in Q1 2016 and held it in 6 quarters. The position peaked at $10.8K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

IFP Advisors reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
IFP Advisors sold 49 Cidara Therapeutics shares in Q1 2026, an estimated $10.8K.
IFP Advisors first reported a position in Cidara Therapeutics in Q1 2016 and held it in 6 quarters.
IFP Advisors's Cidara Therapeutics position peaked at $10.8K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.